Literature DB >> 34491405

Nicotine preference and affective behavior of Cd81 knockout mice.

R Logan Murphy1,2, Laura L Locklear1,3, M Haris Niaz1, Rebecca L Walton1,4, Alexandra D Hudson1,5, Karl J Fryxell6.   

Abstract

RATIONALE: Cd81 -/- (knockout) mice have previously been reported to have reduced cocaine preference and increased striatal dopamine content and dopamine turnover, but normal learning and memory in the Morris water maze. The effects of Cd81 on other behaviors and drugs of abuse have not been investigated. OBJECTIVES AND METHODS: We measured the effects of Cd81 -/- in a modified two-bottle choice test for nicotine, as well as in somatic signs of nicotine withdrawal, four tests of affective behavior, and tyrosine hydroxylase gene expression assays.
RESULTS: We found that Cd81 loss-of-function significantly increased voluntary nicotine consumption and somatic signs of nicotine withdrawal. Nicotine consumption of Cd81 -/- female mice increased for 3 weeks and then remained relatively stable for the next 5 weeks, suggesting that their nicotine consumption continued to be limited by aversion to higher nicotine doses. Cd81 -/- also produced a dramatic and significant increase in struggling in the forced swim test and a significant increase in the time spent in the light chamber of the light/dark box. The elevated plus maze and the tail suspension test did not show a main effect of genotype. Therefore, we conclude that Cd81 did not have an overall effect on anxiety- or depression-like behavior. Tyrosine hydroxylase mRNA levels were unchanged.
CONCLUSIONS: Cd81 knockouts have a strongly increased nicotine preference, plus a proactive response to specific stressful situations. Together with reports of increased striatal dopamine content and anecdotal reports of increased aggressiveness, these provide intriguing parallels to some aspects of post-traumatic stress disorder.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cd81; Nicotine; Nicotine withdrawal; PTSD; Stress-coping strategies

Mesh:

Substances:

Year:  2021        PMID: 34491405     DOI: 10.1007/s00213-021-05966-w

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus.

Authors:  Amine Bahi; Frederic Boyer; Tal Kafri; Jean-Luc Dreyer
Journal:  Eur J Neurosci       Date:  2004-03       Impact factor: 3.386

2.  Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.

Authors:  Ana M Basso; Kelly B Gallagher; Natalie A Bratcher; Jorge D Brioni; Robert B Moreland; Gin C Hsieh; Karla Drescher; Gerard B Fox; Michael W Decker; Lynne E Rueter
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

3.  In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour.

Authors:  Amine Bahi; Frederic Boyer; Manoj Kolira; Jean-Luc Dreyer
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

Review 4.  Electric foot shock stress: a useful tool in neuropsychiatric studies.

Authors:  Anjana Bali; Amteshwar Singh Jaggi
Journal:  Rev Neurosci       Date:  2015       Impact factor: 4.353

5.  Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma.

Authors:  Naomi Breslau; Glenn C Davis; Lonni R Schultz
Journal:  Arch Gen Psychiatry       Date:  2003-03

Review 6.  Nicotine addiction.

Authors:  Neal L Benowitz
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

Review 7.  The mouse light/dark box test.

Authors:  Michel Bourin; Martine Hascoët
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

Review 8.  Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model.

Authors:  W Adriani; G Laviola
Journal:  Behav Pharmacol       Date:  2004-09       Impact factor: 2.293

9.  The effect of cholinoceptor agonists and neurotoxins on the release of vasopressin in the rat in relation to the subunit composition of the cholinoceptor.

Authors:  G W Bisset; K M Fairhall
Journal:  Neurosci Lett       Date:  1995-03-24       Impact factor: 3.046

Review 10.  Sibutramine and energy balance.

Authors:  A Astrup; D L Hansen; C Lundsgaard; S Toubro
Journal:  Int J Obes Relat Metab Disord       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.